Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats earnings expectations. Reported EPS is ...

Quarter Highlighted by GEO-MVA Acceleration Amid Global Mpox Emergency, Gedeptin(R) Expansion Into New Solid Tumor Programs, and Strong GEO-CM04S1 Clinical Data in Immunocompromised Patients Company ...

New York-based biotech startup Panther Life Sciences will expand its presence in Pittsburgh after completing a successful ...

Regular orange juice consumption reprograms immune-cell gene activity linked to blood pressure, lipid metabolism, and ...

Seasoned global pharmaceutical executive, Mr Brent MacGregor, joins Vaxxas Board to accelerate self-administered HD-MAP vaccines for global use;SPRIM Global Investment’s Co-Founder and Managing ...

Bionano Genomics, Inc. ( BNGO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being ...

Discover key insights from GeoVax Labs’ Q3 2025 earnings call—expedited vaccine trials, partnership updates & clinical progress.

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

Pfizer has fended off Nova Nordisk for control of the next-gen weight-loss drug developer Metsera. Meanwhile, Resmed watches ...

Genetic Testing Market - Test Types, Technologies and Distribution Channels" has been added to ResearchAndMarkets.com's offering. The global DTC genetic testing market is heading for significant ...

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS PanelEnables ultra-low variant detection across a range of key MRD targets in AML, including very large FLT3-ITDsOxford, UK ...